Intralesional administration of epidermal growth factor‐based formulation (Heberprot‐P) in chronic diabetic foot ulcer: treatment up to complete wound closure

Previous studies have shown that an epidermal growth factor‐based formulation (Heberprot‐P) can enhance granulation of high‐grade diabetic foot ulcers (DFU). The aim of this study was to explore the clinical effects of this administration up to complete wound closure. A pilot study in 20 diabetic pa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int Wound J
Autors principals: Fernández‐Montequín, José I, Betancourt, Blas Y, Leyva‐Gonzalez, Gisselle, Mola, Ernesto L, Galán‐Naranjo, Katia, Ramírez‐Navas, Mayte, Bermúdez‐Rojas, Sergio, Rosales, Felix, García‐Iglesias, Elizeth, Berlanga‐Acosta, Jorge, Silva‐Rodriguez, Ricardo, Garcia‐Siverio, Marianela, Martinez, Luis H
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2009
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7951202/
https://ncbi.nlm.nih.gov/pubmed/19291119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1742-481X.2008.00561.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars